"APAC healthcare is leaping generations rapidly, and is a growing consumer of novel disposable medical devices."
Haifa, Israel (PRWEB) June 25, 2012
OHK Medical Devices, the producer of the single-use, sterile tourniquet device HemaClear®, announced today that it has expanded its international business activity into the Asia Pacific region. The company has entered an exclusive agreement in South Korea with AMT Advanced Medical Technology, which is part of the company's five year plan to enter the APAC market. The company will formally launch into APAC at MEDinIsrael. This is the first medical devices summit in Israel with a focus on Asia. MEDinIsrael will take place on the 26-28 of June at the Carlton Hotel in Tel Aviv.
The company is currently in negotiations with developed and developing nations across the region. “APAC healthcare is leaping generations rapidly, and is a growing consumer of novel disposable medical devices,” said Oren Gavriely, CEO of OHK Medical Devices. “HemaClear® enables the most rural of locations to provide a standard equal to Massachusetts General Hospital, in Boston.”
HemaClear® is the original sterile, proprietary simple and effective single-use exsanguinating tourniquet. The device is comprised of a silicone band, sterile stockinet, and attached straps. Based upon our patented “grab and pull” method, HemaClear® is able to create a sterile and bloodless field within seconds. It is a cost effective device that replaces the need for extensive and expensive operating room equipment. HemaClear® has been proven successful and medically safe worldwide in over 500,000 surgical cases, both in the OR and in the field, including disaster-struck areas across the world.
Founded in 1999, HemaClear® is based in Haifa, Israel, with offices in 30 countries covering over 2000 operating rooms. For more information about HemaClear®, visit http://www.hemaclear.com.